Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 13, 1192-205

Transplantation: Current Developments and Future Directions; The Future of Clinical Islet Transplantation as a Cure for Diabetes

Affiliations
Review

Transplantation: Current Developments and Future Directions; The Future of Clinical Islet Transplantation as a Cure for Diabetes

Anthony Hogan et al. Front Biosci.

Abstract

Islet transplantation is now a therapeutic option for patients with unstable type 1 diabetes mellitus (T1DM) with hypoglycemic unawareness. The benefits of this treatment include improvement in metabolic control with normalization of A1c and prevention of severe hypoglycemia. Insulin independence and improved quality of life can be reproducibly obtained by transplanting adequate islet numbers. Current obstacles to the widespread application of beta-cell replacement therapies include limited islet availability and the need for chronic immunosuppression. The emergence of promising interventions may be of assistance in improving islet recovery and favoring engraftment of smaller islet masses with comparable or better efficacy. In the future, regenerative efforts will contribute to overcoming this limitation as well. Combining these approaches with the development of safe immune interventions to induce self tolerance or to induce the permanent acceptance of transplanted tissues will be necessary to achieve long-term success. The steady progress and promising results of recent clinical trials justifies a great optimism toward the widespread application of beta-cell replacement as a treatment of choice for patients with diabetes.

Similar articles

  • Overcoming the Challenges Now Limiting Islet Transplantation: A Sequential, Integrated Approach
    A Pileggi et al. Ann N Y Acad Sci 1079, 383-98. PMID 17130583. - Review
    Steady improvements in islet cell processing technology and immunosuppressive protocols have made pancreatic islet transplantation a clinical reality for the treatment of …
  • Allogeneic Islet Transplantation
    S Marzorati et al. Expert Opin Biol Ther 7 (11), 1627-45. PMID 17961088. - Review
    Significant progress has been made in the field of beta-cell replacement therapies by islet transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Rec …
  • Current Status of Islet Cell Transplantation
    H Ichii et al. J Hepatobiliary Pancreat Surg 16 (2), 101-12. PMID 19110649. - Review
    Despite substantial advances in islet isolation methods and immunosuppressive protocol, pancreatic islet cell transplantation remains an experimental procedure currently …
  • Clinical Islet Transplantation
    A Pileggi et al. Minerva Endocrinol 31 (3), 219-32. PMID 17213789. - Review
    Achieving stable metabolic control in patients with type 1 diabetes mellitus (T1DM) is highly desirable and may contribute to delaying and/or preventing the development o …
  • Islet Transplantation in Patients With Diabetes Mellitus: Choice of Immunosuppression
    SA Nanji et al. BioDrugs 18 (5), 315-28. PMID 15377174. - Review
    Islet transplantation offers patients with type 1 diabetes mellitus freedom from long-term insulin therapy and a degree of metabolic control that is far superior to injec …
See all similar articles

Cited by 22 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback